risks of taking compounded semaglutide FDA alerts health care providers, compounders and patients dosing errors associated with injectable products Semaglutide generic: What you need

Management of ventricular arrhythmias and sudden cardiac death risk related to ischemic and nonischemic cardiomyopathy

Engage in daily physical activity and regular exercise to improve insulin sensitivity and hormone balance

Glucose-dependent insulinotropic polypeptide (GIP) is another incretin hormone that modulates the secretion of insulin and glucagon (GCG)

Abstract Purpose To assess and compare the therapeutic efficacy of Liraglutide, Tirzepatide, and Retatrutide in treating diabetic kidney disease (DKD) in db/db mice

The risks are substantial and currently undefined

Conclusions Evidence accrued so far suggest that GLP-1RA could exert a modest renal benefit alongside CV protection, justifying its place as second-line drug in patients with T2D and CKD not achieving glycemic control with SGLT-2i and metformin according to KDIGO guidelines [87]